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Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disorder with heterogeneous clinical presentation and complex
etiology involving the interplay between genetic, epigenetic, environmental and hormonal factors. Many common SNPs
identiﬁed by genome wide-association studies (GWAS) explain only a small part of the disease heritability suggesting the
contribution from rare genetic variants, undetectable in GWAS, and complex epistatic interactions. Using targeted re-
sequencing of coding and conserved regulatory regions within and around 215 candidate genes selected on the basis of their
known role in autoimmunity and genes associated with canine immune-mediated diseases, we identiﬁed a rare regulatory
variant rs200395694:G > T located in intron 4 of the MEF2D gene encoding the myocyte-speciﬁc enhancer factor 2D
transcription factor and associated with SLE in Swedish cohorts (504 SLE patients and 839 healthy controls, p= 0.014,
CI= 1.1–10). Fisher’s exact test revealed an association between the genetic variant and a triad of disease manifestations
including Raynaud, anti-U1-ribonucleoprotein (anti-RNP), and anti-Smith (anti-Sm) antibodies (p= 0.00037) among the
patients. The DNA-binding activity of the allele was further studied by EMSA, reporter assays, and minigenes. The region
has properties of an active cell-speciﬁc enhancer, differentially affected by the alleles of rs200395694:G > T. In addition, the
risk allele exerts an inhibitory effect on the splicing of the alternative tissue-speciﬁc isoform, and thus may modify the target
gene set regulated by this isoform. These ﬁndings emphasize the potential of dissecting traits of complex diseases and
correlating them with rare risk alleles with strong biological effects.
Introduction
Systemic lupus erythematosus (SLE) is a chronic inﬂam-
matory autoimmune disease that predominantly affects
women of childbearing age [1]. A number of studies
exploring the genetic basis of SLE in diverse populations
identiﬁed over 40 risk loci [2], however it was estimated
that these loci explain only about 30% of SLE heritability
[3], indicating that disease pathogenesis results from a
combined effect of different mechanisms and even a larger
number of genes. The recently proposed omnigenic model
of complex traits suggests that virtually any gene with
regulatory variants active in relevant tissue may contribute
to disease pathogenesis [4]. Genes are highly interconnected
within the cell-speciﬁc gene networks, and thus any effect
on one gene with regulatory function, that is not even
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